Arch Clin Neuropsychol. 2022 Jan 17;37(1):125-132. doi: 10.1093/arclin/acab044.
Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system affecting patients' well-being and quality of life. Pythagorean Self-Awareness Intervention (PSAI) is a novel non-pharmaceutical intervention with significant benefits both in MS and other chronic diseases. In this study, the longstanding effectiveness of PSAI was investigated.
This was a two-arm quasi-experimental pragmatic trial in relapsing-remitting MS patients (23 in the PSAI and 21 in the control group). PSAI patients received an 8-week training period and then they performed PSAI at home for another 16 weeks. Assessments took place at baseline, 8 weeks, and 24 weeks. These included cognition, fatigue, perceived stress, and hair cortisol.
Significant group × time interactions favoring PSAI were found during the first 8-week period for information processing speed, fatigue, and perceived stress. However, only verbal memory was found to be significantly improved in the PSAI group during the 24-week follow-up period. There were no significant group × time differences with respect to hair cortisol. No side effects were noted and compliance was excellent.
PSAI was mostly effective during the first 8-week training period. Its benefits worn out during the non-training period, albeit we observed a delayed significant improvement of verbal memory. Our findings will help to further refine the technique, either by extending the training period and/or by including booster sessions, throughout the PSAI treatment. This study provided Class III evidence for PSAI.
多发性硬化症(MS)是一种影响患者健康和生活质量的中枢神经系统自身免疫性疾病。毕达哥拉斯自我意识干预(PSAI)是一种新的非药物干预措施,在 MS 和其他慢性疾病中均有显著疗效。本研究旨在探讨 PSAI 的长期疗效。
这是一项针对复发缓解型 MS 患者的两臂准实验性实用试验(PSAI 组 23 例,对照组 21 例)。PSAI 组患者接受 8 周的培训期,然后在家中进行另外 16 周的 PSAI。在基线、8 周和 24 周进行评估。评估内容包括认知、疲劳、感知压力和头发皮质醇。
在最初的 8 周内,PSAI 组在信息处理速度、疲劳和感知压力方面表现出显著的组间时间交互作用。然而,只有在 24 周的随访期间,PSAI 组的言语记忆才显著改善。头发皮质醇方面没有显著的组间时间差异。没有观察到不良反应,依从性极好。
PSAI 在最初的 8 周培训期间效果显著。其益处在非培训期间逐渐消失,尽管我们观察到言语记忆的延迟显著改善。我们的研究结果将有助于进一步完善该技术,无论是通过延长培训期和/或包括强化课程,贯穿 PSAI 治疗过程。本研究为 PSAI 提供了 III 级证据。